The importance of patient life engagement as a treatment goal in adults living with schizophrenia: a plain language summary

Plain Language SummaryWhat is this summary about?Schizophrenia is a serious mental health condition that affects how people think, feel, and behave. It can cause hallucinations, delusions, and altered behaviors that change how a person experiences and understands reality. People with schizophrenia often feel less engaged with life. This means different things to different people and could include feeling less productive or energetic, not wanting to be around others, and feeling less like themselves. Improving patient life engagement can be an important goal for people with schizophrenia when they receive treatment.This summary covers two studies about measuring and improving life engagement for people with schizophrenia. In the first study, published in 2024, researchers interviewed adults with schizophrenia and experts to understand what questions are relevant to measure life engagement and then developed a new tool as a result. The other study, published in 2025, used this new tool to measure if life engagement and daily functioning improved over time with a medication called brexpiprazole, which is approved for treating schizophrenia.What were the results?In the first study, researchers selected 14 relevant questions (or ‘items’) to include in the new tool. The tool was named the ‘14-item life-engagement scale’. Importantly, adults living with schizophrenia said engagement with life is meaningful to them.In the second study, the 14-item life-engagement scale helped researchers to measure that life engagement showed improvements with brexpiprazole treatment, and that daily functioning tended to improve at the same time.What do the results mean?For people living with schizophrenia, improving life engagement is meaningful, and treatments such as brexpiprazole may help them to feel more engaged with life and better able to function in daily life.How to say…Antipsychotic: an-tee-sy-KOT-ikBrexpiprazole: brex-PIP-ruh-zohlPlacebo: pluh-SEE-bohSchizophrenia: skit-zoh-FREE-nee-uhPatient life engagement: How involved people feel with life and how this affects their feelings, thoughts, activities, and social lives. It is a person’s ability to participate in activities which give their life meaning.This is an abstract of the Plain Language Summary of Publication article.View the full Plain Language Summary PDF of this article to read the full-textLink to original article here and here

Authors

Institutions

Publication Details

Journal
Current Medical Research and Opinion
Published
2026-06-26
DOI
https://doi.org/10.1080/03007995.2026.2687467
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The importance of patient life engagement as a treatment goal in adults living with schizophrenia: a plain language summary

Zahinoor Ismail, Anja Farovik, Shivani Kapadia, Roger S. McIntyre et al.
Current Medical Research and Opinion
Schizophrenia research and treatment
article

The importance of patient life engagement as a treatment goal in adults living with schizophrenia: a plain language summary

Zahinoor Ismail, Anja Farovik, Shivani Kapadia, Roger S. McIntyre, Anton M. Palma, T. Michelle Brown, Stéphane A. Régnier, Mirline Milien, Zhen Zhang, Stine R. Meehan
article en

Abstract

Plain Language SummaryWhat is this summary about?Schizophrenia is a serious mental health condition that affects how people think, feel, and behave. It can cause hallucinations, delusions, and altered behaviors that change how a person experiences and understands reality. People with schizophrenia often feel less engaged with life. This means different things to different people and could include feeling less productive or energetic, not wanting to be around others, and feeling less like themselves. Improving patient life engagement can be an important goal for people with schizophrenia when they receive treatment.This summary covers two studies about measuring and improving life engagement for people with schizophrenia. In the first study, published in 2024, researchers interviewed adults with schizophrenia and experts to understand what questions are relevant to measure life engagement and then developed a new tool as a result. The other study, published in 2025, used this new tool to measure if life engagement and daily functioning improved over time with a medication called brexpiprazole, which is approved for treating schizophrenia.What were the results?In the first study, researchers selected 14 relevant questions (or ‘items’) to include in the new tool. The tool was named the ‘14-item life-engagement scale’. Importantly, adults living with schizophrenia said engagement with life is meaningful to them.In the second study, the 14-item life-engagement scale helped researchers to measure that life engagement showed improvements with brexpiprazole treatment, and that daily functioning tended to improve at the same time.What do the results mean?For people living with schizophrenia, improving life engagement is meaningful, and treatments such as brexpiprazole may help them to feel more engaged with life and better able to function in daily life.How to say…Antipsychotic: an-tee-sy-KOT-ikBrexpiprazole: brex-PIP-ruh-zohlPlacebo: pluh-SEE-bohSchizophrenia: skit-zoh-FREE-nee-uhPatient life engagement: How involved people feel with life and how this affects their feelings, thoughts, activities, and social lives. It is a person’s ability to participate in activities which give their life meaning.This is an abstract of the Plain Language Summary of Publication article.View the full Plain Language Summary PDF of this article to read the full-textLink to original article here and here

Current Medical Research and Opinion
Allen Institute for Brain Science (US), Lundbeck (Denmark) (DK), University of Toronto (CA), University of Exeter (GB), O'Brien Institute (AU), RTI Health Solutions (US), Otsuka Pharmaceutical (Spain) (ES), Health & Life (Taiwan) (TW)
H. Lundbeck A/S, Otsuka Pharmaceutical Development and Commercialization
Openalex Percentile: Top 7%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.